Vaccine trial for stubborn warts on hands or feet
Part of Infections, Skin clinical trials.
This Phase 3 trial tests a nonavalent HPV vaccine to treat long-lasting, hard-to-treat warts on the hands or feet. If you have tried standard treatments and the warts keep coming back or cause trouble, the vaccine may help your body clear the warts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 15 years old and have had palmar or plantar warts for over 1 year
- Have many warts or a large total wart area (at least 5 warts or at least 4 cm² total)
- Have already tried two different treatment approaches in the past year (topical salicylic acid and freezing with liquid nitrogen), with the most recent treatment within 3 weeks
- Warts must be painful and/or cause functional/social discomfort on questionnaires
- Do not use medicines that suppress or change your immune system; you must not have had an HPV vaccine before this study
- If you can get pregnant: have a negative pregnancy test and use effective birth control during vaccination and for 6 months after
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an HPV vaccine can help shrink or clear cutaneous (skin) warts that have not responded to prior treatments. Participants get the study vaccine or a placebo to compare results and safety.
This Phase 2 study tests giving a Candida antigen plus a bivalent HPV vaccine to help shrink or clear multiple common skin warts. It may help people with warts on different body areas, with different sizes or how long they’ve had them.
This early-phase trial tests whether using freezing (cryotherapy) together with a vaccine shot placed into the wart works better than freezing alone or the vaccine alone. It may help people with many skin warts, but whether you can join depends on your health history and current treatments.
This study tests a new injection-based treatment for common warts (the bumpy growths on skin caused by a virus). Researchers want to see if this approach works better than current options and is safe for patients.
This trial tests two versions of an at-home medicine to see how well they clear warts. Participants are randomly assigned to the study medicine or a placebo (inactive treatment) so researchers can compare results fairly.
This study is testing an ointment called tirbanibulin to treat warts on the hands of children and teens. It may offer a new option if other treatments haven't worked.
Hear when a new Palmar or Plantar Warts trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.